Lars Sandman

Datos Biográficos

ID323937
NOMBRELars Sandman
NOMBRESLars
APELLIDOSandman
FIRMASANDMAN L
AFILIACIONESLinköping University
ORCID0000-0003-0987-7653
VERIFICADOSí
TOTAL DE OBRAS18
TOTAL DE CITAS11
TOTAL COMO AUTOR18
TOTAL COMO EDITOR0
PRIMER AÑO DE PUBLICACIÓN2009
AÑO MÁS RECIENTE DE PUBLICACIÓN2026
ÍNDICE H2

  • Cost-effectiveness, pharmaceutical pricing and the value flower – doing some gardening

    Open AccessLars Sandman, Markku Henriksson et al.ARTICLEMedicine Health Care and Philosophy2026

    During the recent years, ISPOR has proposed a number of values that could be taken into account in health technology assessments, for instance when doing an evaluation of what determines society’s price for pharmaceutical treatments. These includes values that are not usually considered in health economic evaluation of pharmaceutical pricing, for instance option value, the value of hope and knowing, insurance value, the value of avoiding contagio…

  • Using a lottery to resolve indeterminacy when allocating resources for drugs for rare diseases

    Open AccessKenneth Bond, Lars Sandman et al.ARTICLEJournal of Medical Ethics2026

    Healthcare resource allocation decisions for high-cost drugs for rare diseases (DRDs) raise several challenges for decision makers, and, given the complexity of the decisions and the limited funding available for DRDs, it is reasonable to anticipate indeterminacy arising about which DRDs to fund. We argue that when indeterminacy does arise, one might consider resolving it by using a lottery. We examine the extent to which a lottery and the common…

  • Is a larger patient benefit always better in healthcare priority setting

    Open AccessLars Sandman, Jan Liliemark et al.ARTICLEMedicine Health Care and Philosophy2024

    When considering the introduction of a new intervention in a budget constrained healthcare system, priority setting based on fair principles is fundamental. In many jurisdictions, a multi-criteria approach with several different considerations is employed, including severity and cost-effectiveness. Such multi-criteria approaches raise questions about how to balance different considerations against each other, and how to understand the logical or …

  • How did European countries set health priorities in response to the Covid-19 threat? A comparative document analysis of 24 pandemic preparedness plans across the Euro region

    Open AccessIestyn Williams, Lydia Kapiriri et al.ARTICLEHealth Policy2024

    The COVID-19 pandemic has forced governments across the world to consider how to prioritise the allocation of scarce resources. There are many tools and frameworks that have been designed to assist with the challenges of priority setting in health care. The purpose of this study was to examine the extent to which formal priority setting was evident in the pandemic plans produced by countries in the World Health Organisation's EURO region, during …

  • Should relational effects be considered in health care priority setting

    Open AccessErik Gustavsson, Niklas Juth et al.ARTICLEBioethics2023

    It is uncontroversial to claim that the extent to which health care interventions benefit patients is a relevant consideration for health care priority setting. However, when effects accrue to the individual patient, effects of a more indirect kind may accrue to other individuals as well, such as the patient's children, friends, or partner. If, and if so how, such relational effects should be considered relevant in priority setting is contentious…

  • Rare and common diseases should be treated equally and why the article by de Magalhaes somewhat misses its’ mark

    Lars SandmanARTICLEJournal of Medical Ethics2022

  • The ethics of disease-modifying drugs targeting Alzheimer disease

    Erik Gustavsson, Pauline Raaschou et al.ARTICLEJournal of Medical Ethics2022

  • Prioritization of Covid-19 vaccination. The added value of the “Validate” approach

    Open AccessPietro Refolo, Bart Bloemen et al.ARTICLEHealth Policy2022

  • Priority setting and equity in Covid-19 pandemic plans

    Open AccessLydia Kapiriri, Suzanne N Kiwanuka et al.ARTICLEHealth Policy and Planning2022

    Priority setting represents an even bigger challenge during public health emergencies than routine times. This is because such emergencies compete with routine programmes for the available health resources, strain health systems and shift health-care attention and resources towards containing the spread of the epidemic and treating those that fall seriously ill. This paper is part of a larger global study, the aim of which is to evaluate the degr…

  • Priority setting during the Covid-19 pandemic

    Open AccessIestyn Williams, Beverley M Essue et al.ARTICLEBMJ Global Health2021

    Development of vaccines is a major breakthrough in the fight against the SARS-CoV-2 virus. Much attention has been paid to how to prioritise between patient groups for vaccination and how to ensure equity, especially in low-income countries, but there are other important decisions that need to be made. These decisions include: (a) choosing between the various vaccines that will become available, (b) continuing to invest in other aspects of the CO…

  • Novel drug candidates targeting Alzheimer’s disease

    Open AccessErik Gustavsson, Pauline Raaschou et al.ARTICLEJournal of Medical Ethics2021

    Intensive research is carried out to develop a disease-modifying drug for Alzheimer’s disease (AD). The development of drug candidates that reduce Aß or tau in the brain seems particularly promising. However, these drugs target people at risk for AD, who must be identified before they have any, or only moderate, symptoms associated with the disease. There are different strategies that may be used to identify these individuals (eg, population scre…

  • Should we accept a higher cost per health improvement for orphan drugs? A review and analysis of egalitarian arguments

    Open AccessNiklas Juth, Markku Henriksson et al.ARTICLEBioethics2021

    In recent years, the issue of accepting a higher cost per health improvement for orphan drugs has been the subject of discussion in health care policy agencies and the academic literature. This article aims to provide an analysis of broadly egalitarian arguments for and against accepting higher costs per health improvement. More specifically, we aim to investigate which arguments one should agree upon putting aside and where further explorations …

  • Patient experience of implant loss after immediate breast reconstruction

    Open AccessLinn Weick, Alice Ericson et al.ARTICLEHealth Care For Women International2021

    Immediate breast reconstruction (IBR) is an integral part of modern breast cancer treatment. Our aim was to investigate patient experience with implant loss after IBR by using interpretative phenomenological analysis (IPA). We conducted semi-structured interviews with eight informants. We analyzed data according to the IPA flexible seven-stage process and four main themes were developed: immediate breast reconstruction as the indisputable choice,…

  • Do not despair about severity—yet

    Mathias Barra, Mari Broqvist et al.ARTICLEJournal of Medical Ethics2020

    In a recent extended essay, philosopher Daniel Hausman goes a long way towards dismissing severity as a morally relevant attribute in the context of priority setting in healthcare. In this response, we argue that although Hausman certainly points to real problems with how severity is often interpreted and operationalised within the priority setting context, the conclusion that severity does not contain plausible ethical content is too hasty. Rath…

  • Rethinking patient involvement in healthcare priority setting

    Open AccessLars Sandman, Bjørn Hofmann et al.ARTICLEBioethics2020

    With healthcare systems under pressure from scarcity of resources and ever‐increasing demand for services, difficult priority setting choices need to be made. At the same time, increased attention to patient involvement in a wide range of settings has given rise to the idea that those who are eventually affected by priority setting decisions should have a say in those decisions. In this paper, we investigate arguments for the inclusion of patient…

  • Increasing return-to-work among people on sick leave due to common mental disorders

    Open AccessElisabeth Björk Brämberg, Kristina Holmgren et al.ARTICLEBMC Public Health2018

    ClinicalTrials.gov Identifier: NCT03346395 Registered January, 12 2018

  • To Survive Out-of-Hospital Cardiac Arrest

    Open AccessAnders Bremer, Karin Dahlberg et al.ARTICLEQualitative Health Research2009Citada por: 7Referencias: 24

    The primary responsibility of prehospital emergency personnel at out-of-hospital cardiac arrests (OHCA) is to provide lifesaving care. Ethical considerations, decisions, and actions should be based in the patient's beliefs about health and well-being. In this article, we describe patients' experiences of surviving OHCA. By using a phenomenological approach, we focus on how OHCA influences patients' well-being over time. Nine survivors were interv…

  • Experiencing Out-of-Hospital Cardiac Arrest

    Open AccessAnders Bremer, Karin Dahlberg et al.ARTICLEQualitative Health Research2009Citada por: 4Referencias: 24

    When patients suffer out-of-hospital cardiac arrests (OHCA), significant others find themselves with no choice about being there. After the event they are often left with unanswered questions about the life-threatening circumstances, or the patient's death, or emergency treatment and future needs. When it is unclear how the care and the event itself will affect significant others' well-being, prehospital emergency personnel face ethical decisions…